Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

October 26, 2008

CeNeRx BioPharma Completes $15 Million Series B Financing

October 17, 2008

Sirion Therapeutics Announces Positive Pivotal Uveitis Data For Durezol™

October 14, 2008

Allure Magazine Names Tria Laser a Beauty Breakthrough Product of 2008

September 17, 2008

Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(TM) Phase IIb Study for Peyronie's Disease

September 17, 2008

Stiefel Laboratories Completes Acquisition of Barrier Therapeutics

August 6, 2008

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

July 14, 2008

Dynova Laboratories Brings OTC Healhcare Marketing Expertise To Natural Products Market, Acquires “Sinus Buster” Company

July, 2008

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX™ Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

June 03, 2008

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

April 7, 2008

New Microfluidic Technology for Proteomic Research

April 1, 2008

Advion Acquires the Assets of its BioSystems Manufacturing Partner

March 12, 2008

Barrier Therapeutics Announces Top Management Succession Plan

January 25, 2008

CeNeRx BioPharma Announces Successful Completion of Phase 1 Clinical Program for Novel Antidepressant Agent Tyrima™

January 15, 2008

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial of Unit Dose Budesonide in Children with Asthma

January 7, 2008